108 related articles for article (PubMed ID: 5034813)
61. Neomycin B-glucoside, a component of media fermented by Streptomyces fradiae 3535.
Perlman D; Cowan SK
J Antibiot (Tokyo); 1974 Aug; 27(8):637-8. PubMed ID: 4436148
[No Abstract] [Full Text] [Related]
62. WS-7338, new endothelin receptor antagonists isolated from Streptomyces sp. No. 7338. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.
Miyata S; Hashimoto M; Masui Y; Ezaki M; Takase S; Nishikawa M; Kiyoto S; Okuhara M; Kohsaka M
J Antibiot (Tokyo); 1992 Jan; 45(1):74-82. PubMed ID: 1312521
[TBL] [Abstract][Full Text] [Related]
63. Metabolic products of microorganisms. 234. Urdamycins, new angucycline antibiotics from Streptomyces fradiae. I. Isolation, characterization and biological properties.
Drautz H; Zähner H; Rohr J; Zeeck A
J Antibiot (Tokyo); 1986 Dec; 39(12):1657-69. PubMed ID: 3818439
[TBL] [Abstract][Full Text] [Related]
64. Ro 22-5417, a new clavam antibiotic from Streptomyces clavuligerus. II. Fermentation, isolation and structure.
Evans RH; Ax H; Jacoby A; Williams TH; Jenkins E; Scannell JP
J Antibiot (Tokyo); 1983 Mar; 36(3):213-6. PubMed ID: 6833141
[TBL] [Abstract][Full Text] [Related]
65. Elaiomycins K and L, new azoxy antibiotics from Streptomyces sp. Tü 6399*.
Manderscheid N; Helaly SE; Kulik A; Wiese J; Imhoff JF; Fiedler HP; Süssmuth RD
J Antibiot (Tokyo); 2013 Feb; 66(2):85-8. PubMed ID: 23149516
[TBL] [Abstract][Full Text] [Related]
66. A new microbial metabolite, sphydrofuran. I. Isolation and the structure of a hydrolysis product.
Umezawa S; Usui T; Umezawa H; Tsuchiya T; Takeuchi T
J Antibiot (Tokyo); 1971 Feb; 24(2):85-92. PubMed ID: 4323586
[No Abstract] [Full Text] [Related]
67. L-155,175: a new antiparasitic macrolide. Fermentation, isolation and structure.
Goetz MA; McCormick PA; Monaghan RL; Ostlind DA; Hensens OD; Liesch JM; Albers-Schonberg G
J Antibiot (Tokyo); 1985 Feb; 38(2):161-8. PubMed ID: 3997663
[TBL] [Abstract][Full Text] [Related]
68. Improved production of pentostatin and identification of fermentation cometabolites.
Showalter HD; Bunge RH; French JC; Hurley TR; Leeds RL; Leja B; McDonnell PD; Edmunds CR
J Antibiot (Tokyo); 1992 Dec; 45(12):1914-8. PubMed ID: 1490883
[TBL] [Abstract][Full Text] [Related]
69. New type II manumycins produced by Streptomyces nodosus ssp. asukaensis and their biosynthesis.
Hu Y; Floss HG
J Antibiot (Tokyo); 2001 Apr; 54(4):340-8. PubMed ID: 11426658
[TBL] [Abstract][Full Text] [Related]
70. WS9761 A and B: new non-steroidal androgen-receptor antagonists produced by a Streptomyces.
Hori Y; Abe Y; Nakajima H; Shigematsu N; Takase S; Goto T; Okuhara M; Kohsaka M
J Antibiot (Tokyo); 1993 Dec; 46(12):1901-3. PubMed ID: 8294251
[No Abstract] [Full Text] [Related]
71. A novel neuronal cell protecting substance, aestivophoenin C, produced by Streptomyces purpeofuscus.
Kunigami T; Shin-Ya K; Furihata K; Furihata K; Hayakawa Y; Seto H
J Antibiot (Tokyo); 1998 Sep; 51(9):880-2. PubMed ID: 9820239
[No Abstract] [Full Text] [Related]
72. Biotransformation of selamectin with Streptomyces lydicus SX-1298 using a novel static agar fermentation system with Reemay mesh.
Pacey MS; Barnes MM; Monday RA; Ritzau M; Wellington EM
J Antibiot (Tokyo); 2001 May; 54(5):448-54. PubMed ID: 11480889
[TBL] [Abstract][Full Text] [Related]
73. Fattiviracin A1, a novel antiherpetic agent produced by Streptomyces microflavus Strain No. 2445. I. Taxonomy, fermentation, isolation, physico-chemical properties and structure elucidation.
Uyeda M; Yokomizo K; Miyamoto Y; Habib EE
J Antibiot (Tokyo); 1998 Sep; 51(9):823-8. PubMed ID: 9820232
[TBL] [Abstract][Full Text] [Related]
74. Biosynthesis of polyketomycin produced by Streptomyces diastatochromogenes Tü 6028.
Paululat T; Zeeck A; Gutterer JM; Fiedler HP
J Antibiot (Tokyo); 1999 Feb; 52(2):96-101. PubMed ID: 10344562
[TBL] [Abstract][Full Text] [Related]
75. Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-L-lysine and N5-iminoethyl-L-ornithine.
Wolff DJ; Lubeskie A; Gauld DS; Neulander MJ
Eur J Pharmacol; 1998 Jun; 350(2-3):325-34. PubMed ID: 9696424
[TBL] [Abstract][Full Text] [Related]
76. FR112123, a new oligopeptide antibiotic from Streptomyces viridochromogenes. Taxonomy, fermentation, isolation, physico-chemical properties, structure and biological activity.
Fujie A; Iwamoto T; Shigematsu N; Ezaki M; Hino M; Hashimoto S; Okuhara M; Kohsaka M; Imanaka H
J Antibiot (Tokyo); 1990 May; 43(5):449-55. PubMed ID: 2193008
[TBL] [Abstract][Full Text] [Related]
77. New antibiotic U-64846: fermentation, isolation and characterization.
Dolak LA; Castle TM; Hannon BR; Reusser F
J Antibiot (Tokyo); 1984 Feb; 37(2):96-102. PubMed ID: 6706857
[TBL] [Abstract][Full Text] [Related]
78. Quanolirones I and II, two new human cytomegalovirus protease inhibitors produced by Streptomyces sp. WC76535.
Qian-Cutrone J; Kolb JM; McBrien K; Huang S; Gustavson D; Lowe SE; Manly SP
J Nat Prod; 1998 Nov; 61(11):1379-82. PubMed ID: 9834156
[TBL] [Abstract][Full Text] [Related]
79. Antimetabolites produced by microorganisms. V. L-2-amino-4-methoxy-trans-3-butenoic acid.
Scannel JP; Pruess DL; Demny TC; Sello LH; Williams T
J Antibiot (Tokyo); 1972 Feb; 25(2):122-7. PubMed ID: 4624612
[No Abstract] [Full Text] [Related]
80. Two new doramectin analogs from Streptomyces avermitilis NEAU1069: fermentation, isolation and structure elucidation.
Wang XJ; Wang JJ; Wang JD; Zhang J; Xu MD; Xiang WS
J Antibiot (Tokyo); 2011 Aug; 64(8):591-4. PubMed ID: 21673714
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
